Patients undergoing treatment for ischemic stroke are at greater risk for seizure development.
The effects of ischemic stroke on disability trajectories over an extended period of time were examined.
Patients enrolled in this study had strokes that were mild in severity, reducing the generalizability of these findings to the broader population.
Patients who experience acute coronary syndrome are at greater risk of recurrent ischemic events, including stroke.
All patients included in the study underwent a MRI or multimodal CT approximately 24 hours after onset of stroke.
Long-term, high-dose usage of PPIs increases the risk of first-time ischemic stroke and myocardial infarction.
Results from a secondary analysis of the ENCHANTED trial add to a pile of weak data that likely will not affect clinical practice.
Significant infarct progression can make patients ineligible for mechanical thrombectomy.
The findings support the continuation of high-intensity statin therapy after acute ischemic stroke.
Insulin-resistant patients with ischemic stroke or transient ischemic attack and a high risk of myocardial infarction or recurrent stroke are more likely to derive benefit from pioglitazone than those a lower risk.
A better understanding of characteristics of cerebral lesions may help expedite treatment and improve functional outcomes.
The investigators noted that rivaroxaban was associated with significantly reduced length of hospital stay compared with warfarin.
The findings align with current guidelines to administer IV tPA regardless of whether or not a patient with ischemic stroke is set to undergo mechanical thrombectomy.
There is some evidence that suggests intravenous thrombolysis for stroke may impair the blood-brain barrier and cause cerebral edema.
The findings may be less applicable to low-volume stroke centers who have less experience in this treatment.
Investigators found a positive association between higher childhood BMI scores and early adult ischemic stroke.
THRIVE scores not only accurately predicted good and poor outcomes in stroke patients following IVT or ET, but also the degree of ischemia following these treatments.
Despite disappointing results, tenecteplase's story in stroke treatment might not be over.
Women and patients of African-American race face an increased risk of experiencing poststroke recrudescence.
Only 16% of patients had an adequate response to conventional therapy, with patients who didn't considered "non-responders."
There are a limited number of prediction models that identify patients at risk of major bleeding after stroke or TIA.
Reduced door-to-needle times have been shown to improve outcomes after stroke.
Risk for symptomatic intracranial hemorrhage after endovascular treatment for acute ischemic stroke is significantly higher in real-world practice than rates reported by clinical trials.
No between-group differences were observed for reperfusion success and mortality, among other measures.
Intensive antiplatelet therapy appears to reduce risk of recurrence immediately after stroke, but may pose risks further out.
New research from the American Heart and American Stroke Associations found that many Americans don't know the symptoms of stroke.
The relative risk of developing ischemic stroke was increased in patients with systemic lupus erythematosus, especially within the first year after diagnosis.
Neurologists need to engage their emergency medicine colleagues to identify protocols and pathways for when to trigger appropriate neurological consultation or initiate acute stroke therapies.
Over 32% of patients were functionally independent at 90 days and 37.1% were functionally independent at 2 years.
Pulse pressure was associated with the risk for ischemic stroke in first-ever ischemic stroke patients old than 60 years.
Neurology Advisor Articles
- Increased Epilepsy Risk Identified in Multiple Sclerosis
- Distinct Clinical Characteristics Associated With Subarachnoid Hemorrhage
- Managing Chronic Pain Associated With Traumatic Brain Injury
- Magnesium Plus Environmental Enrichment Boosts Cognition, Memory in Alzheimer's Mouse Model
- Prognostic Significance of Weight Loss in Patients With Early Parkinsonism
- Coffee Consumption May Decrease Stroke Risk
- When and How to Approach Driving Cessation in Patients With Dementia
- NBT System Gets FDA Clearance for Depression Treatment
- Erenumab, Fremanezumab Reduce Migraine Frequency, Burden
- Some Antiepileptic Drugs Associated With Increased Risk for Toxic Epidermal Necrolysis
- Deep Brain Stimulation Improves Survival in Parkinson Disease
- Induced Hypertension Does Not Improve Outcomes in Subarachnoid Hemorrhage, Cerebral Ischemia
- Devices for Acute, Preventive Migraine Care Now Available
- Evolocumab FDA Approved for Stroke Prevention in Cardiovascular Disease
- Depression in Parkinson Disease Linked to Impaired White Matter Integrity